Novel and Innovative Drug Delivery Systems to Overcome Chemoresistance in Human Malignancies
Academic Press Inc (Verlag)
978-0-443-45717-3 (ISBN)
- Noch nicht erschienen (ca. Mai 2026)
- Versandkostenfrei
- Auch auf Rechnung
- Artikel merken
For an academic audience, this book serves as an essential resource to foster interdisciplinary collaboration in cancer research. It equips researchers, clinicians, and industry professionals with the knowledge needed to navigate the evolving landscape of cancer therapeutics, addressing critical challenges in drug delivery and chemoresistance to improve patient outcomes.
Dr. Shuvomoy Banerjee is an accomplished academic and researcher with extensive experience as an editorial board member for several reputable journals, including Reviews in Medical Virology, and as an associate editor for the IAR University Journal. He holds a Ph.D. in cancer biology from Bose Institute, Kolkata, and has post-doctoral research experience at the University of Pennsylvania and Beckman Research Institute. Currently an Assistant Professor at the Institute of Advanced Research, Gandhinagar, Dr. Banerjee specializes in cancer immunology and tumor virology. His prolific contributions include numerous publications in high-impact journals. He has led multiple extramural research projects funded by organizations such as the Science and Engineering Research Board (SERB) and the Gujarat State Biotechnology Mission. His active participation in various scientific organizations underscores his credibility and thought leadership in the field of cancer research. Regenerate response Dr. Dhiraj Bhatia, an associate professor at IIT-Gandhinagar, specializes in DNA nanotechnology, chemical biology, and drug delivery systems. With a Ph.D. from NCBS-TIFR and postdoctoral work including an HFSP fellowship at Institut Curie, he has pioneered research in structural DNA nanotechnology for biomedical applications. His publications in high-impact journals like ACS Nano, Nature Nanotechnology, and Angewandte Chemie showcase his expertise. His work on programmable DNA nanodevices, hydrogels, and targeted drug delivery addresses critical challenges such as cancer chemoresistance. Recognized with awards like the Merck Young Scientist Award and INYAS-INSA Membership, Dr. Bhatia is also an experienced reviewer and mentor, actively organizing interdisciplinary conferences
1. Introduction to Cancer Chemoresistance: Mechanisms and Challenges
2. Impact of Hypoxia, Angiogenesis, and Immune Suppression in Chemoresistance
3. Design and Applications of Nanoparticles, Liposomes, Dendrimers, and Smart Biomaterials-Based Drug Delivery Systems
4. Immunomodulatory Drug Delivery Systems
5. Stimuli-Responsive Drug Delivery Platforms
6. RNA-Based Therapeutics for Overcoming Chemoresistance
7. Drug Repurposing Approaches to Overcome Chemoresistance
8. CRISPR/Cas9 and Gene Editing Approaches as Solutions for Chemoresistance
9. Challenges and Clinical Applications of Novel Drug Delivery Systems
10. Exosome and Extracellular Vesicle-Based Therapeutics
11. Preclinical Models for Evaluating Drug Delivery Systems
12. AI and Machine Learning-Based Drug Design for Overcoming Chemoresistance
| Erscheint lt. Verlag | 1.5.2026 |
|---|---|
| Reihe/Serie | Novel approaches to overcome cancer resistance to conventional therapies |
| Verlagsort | San Diego |
| Sprache | englisch |
| Maße | 191 x 235 mm |
| Gewicht | 450 g |
| Themenwelt | Naturwissenschaften ► Biologie |
| ISBN-10 | 0-443-45717-4 / 0443457174 |
| ISBN-13 | 978-0-443-45717-3 / 9780443457173 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
